These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32800193)

  • 1. Biomarkers in Chronic Obstructive Pulmonary Disease: The Gateway to Precision Medicine.
    Milne S; Sin DD
    Clin Chest Med; 2020 Sep; 41(3):383-394. PubMed ID: 32800193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Challenges of Precision Medicine in COPD.
    Cazzola M; Calzetta L; Rogliani P; Matera MG
    Mol Diagn Ther; 2017 Aug; 21(4):345-355. PubMed ID: 28247183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and sputum protein biomarkers for chronic obstructive pulmonary disease (COPD).
    Moon JY; Leitao Filho FS; Shahangian K; Takiguchi H; Sin DD
    Expert Rev Proteomics; 2018 Nov; 15(11):923-935. PubMed ID: 30362838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
    Sin DD; Hollander Z; DeMarco ML; McManus BM; Ng RT
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1162-70. PubMed ID: 26176936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for precision medicine in airways disease.
    Rooney C; Sethi T
    Ann N Y Acad Sci; 2015 Jun; 1346(1):18-32. PubMed ID: 26099690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex and Gender Omic Biomarkers in Men and Women With COPD: Considerations for Precision Medicine.
    DeMeo DL
    Chest; 2021 Jul; 160(1):104-113. PubMed ID: 33745988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for personalised and biomarker-guided COPD self-treatment approaches.
    Lenferink A; Citgez E; van der Valk PDLPM; van der Palen J; Effing TW; Brusse-Keizer MGJ
    Lancet Respir Med; 2024 Aug; 12(8):e48-e49. PubMed ID: 38885685
    [No Abstract]   [Full Text] [Related]  

  • 8. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precision medicine in chronic obstructive pulmonary disease.
    Halpin DMG
    Chin Med J (Engl); 2022 May; 135(10):1156-1162. PubMed ID: 35787584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Developing Biomarkers in Precision Medicine for Asthma and COPD].
    Hirai K
    Yakugaku Zasshi; 2023; 143(3):249-255. PubMed ID: 36858558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
    Cazzola M; Puxeddu E; Ora J; Rogliani P
    Mol Diagn Ther; 2019 Oct; 23(5):603-614. PubMed ID: 31363933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort.
    Rønnow SR; Sand JMB; Langholm LL; Manon-Jensen T; Karsdal MA; Tal-Singer R; Miller BE; Vestbo J; Leeming DJ
    Respir Res; 2019 Apr; 20(1):63. PubMed ID: 30935391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine in COPD exacerbations.
    Agusti A; Faner R; Celli B; Rodriguez-Roisin R
    Lancet Respir Med; 2018 Sep; 6(9):657-659. PubMed ID: 30029970
    [No Abstract]   [Full Text] [Related]  

  • 14. The Promise of Observational Studies (ECLIPSE, SPIROMICS, and COPDGene) in Achieving the Goal of Personalized Treatment of Chronic Obstructive Pulmonary Disease.
    Rennard SI
    Semin Respir Crit Care Med; 2015 Aug; 36(4):478-90. PubMed ID: 26238636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood biomarkers in chronic airways diseases and their role in diagnosis and management.
    van Bragt JJMH; Vijverberg SJH; Weersink EJM; Richards LB; Neerincx AH; Sterk PJ; Bel EHD; Maitland-van der Zee AH
    Expert Rev Respir Med; 2018 May; 12(5):361-374. PubMed ID: 29575948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular markers in COPD.
    Gonçalves I; Guimarães MJ; van Zeller M; Menezes F; Moita J; Simão P;
    Pulmonology; 2018; 24(4):250-259. PubMed ID: 29898875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asthma-COPD overlap syndrome and precision medicine.
    Bovornkitti S
    Asian Pac J Allergy Immunol; 2017 Mar; 35(1):1-2. PubMed ID: 28431471
    [No Abstract]   [Full Text] [Related]  

  • 18. Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.
    Hollander Z; DeMarco ML; Sadatsafavi M; McManus BM; Ng RT; Sin DD
    Chest; 2017 Feb; 151(2):455-467. PubMed ID: 27693595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease phenotypes, biomarkers, and prognostic indicators.
    Brightling CE
    Allergy Asthma Proc; 2016 Nov; 37(6):432-438. PubMed ID: 27931297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for chronic obstructive pulmonary disease diagnosis and progression: insights, disappointments and promise.
    Mannino DM
    Curr Opin Pulm Med; 2019 Mar; 25(2):144-149. PubMed ID: 30520743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.